TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
72,392
|
308,487
|
18,904 |
Financial expenses |
1,548
|
751
|
699 |
Earnings before taxes |
-334,402
|
-40,204
|
-271,545 |
EBITDA |
-374,763
|
-48,167
|
-271,453 |
Total assets |
1,418,427
|
1,619,605
|
1,411,450 |
Current assets |
1,148,033
|
1,025,428
|
1,088,367 |
Current liabilities |
76,907
|
82,596
|
57,335 |
Equity capital |
1,326,795
|
1,519,251
|
1,333,116 |
- share capital |
13,333
|
12,291
|
11,404 |
Employees (average) |
104
|
89
|
79 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
93.5%
|
93.8%
|
94.5% |
Turnover per employee |
696
|
3,466
|
239 |
Profit as a percentage of turnover |
-461.9%
|
-13.0%
|
-1436.4% |
Return on assets (ROA) |
-23.5%
|
-2.4%
|
-19.2% |
Current ratio |
1492.8%
|
1241.5%
|
1898.3% |
Return on equity (ROE) |
-25.2%
|
-2.6%
|
-20.4% |
Change turnover |
-257,984
|
290,151
|
-124,817 |
Change turnover % |
-78%
|
1582%
|
-87% |
Chg. No. of employees |
15
|
10
|
7 |
Chg. No. of employees % |
17%
|
13%
|
10% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.